- A phase 3 trial to evaluate the efficacy and safety of chiglitazar added to metformin in Chinese patients with type 2 diabetes inadequately controlled on metformin monotherapyGao, L.; Ji, L.; Dong, X.; Cheng, Z.; Zhang, X.; Sun, W.; Ma, J.59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Hamburg, GERMANY, 2023-10-02 To 2023-10-06.
- An open level study to assess the glycemic control effect of metformin and Pioglitazone as add on therapy along with sulfonylurea in uncomplicated type2 diabetes mellitusGoutameswar, Mazumdar; Bikash, Swaika; Anindya, DasguptaJournal of Diabetes Mellitus, 2012, 02(02): 191-195.
- Efficacy and safety of tirzepatide once weekly in Chinese participants with obesity or with overweight and weight-related comorbiditiesZhao, L.; Cheng, Z.; Lu, Y.; Liu, M.; Chen, H.; Zhang, M.; Wang, R.; Wang, Y.; Yuan, Y.; Li, X.59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Hamburg, GERMANY, 2023-10-02 To 2023-10-06.
会议论文
Efficacy and safety of supaglutide as add-on to metformin in patients with type 2 diabetes
22阅读
